JP2018100223A - Food composition for stress reduction - Google Patents
Food composition for stress reduction Download PDFInfo
- Publication number
- JP2018100223A JP2018100223A JP2016245132A JP2016245132A JP2018100223A JP 2018100223 A JP2018100223 A JP 2018100223A JP 2016245132 A JP2016245132 A JP 2016245132A JP 2016245132 A JP2016245132 A JP 2016245132A JP 2018100223 A JP2018100223 A JP 2018100223A
- Authority
- JP
- Japan
- Prior art keywords
- stress
- food composition
- vanillin
- borneol
- stress reduction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 42
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims abstract description 26
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims abstract description 26
- 235000012141 vanillin Nutrition 0.000 claims abstract description 26
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 24
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229940116229 borneol Drugs 0.000 claims abstract description 24
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 24
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- 239000003638 chemical reducing agent Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 244000290333 Vanilla fragrans Species 0.000 description 12
- 235000009499 Vanilla fragrans Nutrition 0.000 description 12
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 12
- 238000012360 testing method Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 239000000284 extract Substances 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 6
- 244000046052 Phaseolus vulgaris Species 0.000 description 6
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 6
- 210000000467 autonomic pathway Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000000949 anxiolytic effect Effects 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000003340 mental effect Effects 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 230000001624 sedative effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 239000007857 degradation product Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 235000015872 dietary supplement Nutrition 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 239000012264 purified product Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 230000000049 anti-anxiety effect Effects 0.000 description 2
- 235000013405 beer Nutrition 0.000 description 2
- 235000012970 cakes Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000008035 nerve activity Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 244000294411 Mirabilis expansa Species 0.000 description 1
- 235000015429 Mirabilis expansa Nutrition 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 208000001388 Opportunistic Infections Diseases 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000009532 heart rate measurement Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000002551 irritable bowel syndrome Diseases 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- 235000020124 milk-based beverage Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000013536 miso Nutrition 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000012958 reprocessing Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Images
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
本発明は、ストレスを低減させるための食品組成物に関し、バニリン及びボルネオールの少なくとも一方を有効成分として含有する食品組成物に関する。 The present invention relates to a food composition for reducing stress, and relates to a food composition containing at least one of vanillin and borneol as an active ingredient.
現代はストレス過負荷の時代である。過度なストレスは免疫系、神経系、消化器系又は循環器系等の広範囲にわたって影響を及ぼし、その結果として多岐にわたる疾患を発現させて、生活の質を低下させる要因となる。 Today is an era of stress overload. Excessive stress affects a wide range of the immune system, nervous system, digestive system or circulatory system, and as a result, causes a wide variety of diseases, thereby reducing the quality of life.
ストレスが原因の一つとなって引き起こされるストレス関連症状としては、免疫系では免疫力の低下による日和見感染症、神経系ではうつ病等の神経症、消化器系では胃・十二指腸潰瘍又は過敏性腸症候群、循環器系では高血圧又は虚血性心疾患等が挙げられる。 Stress-related symptoms caused by stress include opportunistic infections due to decreased immunity in the immune system, neurosis such as depression in the nervous system, gastric / duodenal ulcer or irritable bowel in the digestive system Examples of syndrome and circulatory system include hypertension or ischemic heart disease.
これらの疾患の予防又は改善のため、ストレスの原因を減らすことが根本的な解決方法であるが、それが困難なのが現状であり、日常的に手軽にストレスを低減することのできる技術が望まれている。 Reducing the cause of stress is the fundamental solution for preventing or ameliorating these diseases, but this is currently difficult, and a technology that can easily reduce stress on a daily basis is desired. It is rare.
したがって、本発明は、日常的に手軽に飲食品等として摂取することにより、ストレスを低減する効果を発揮できる食品組成物を提供することを目的とする。 Therefore, an object of this invention is to provide the food composition which can exhibit the effect which reduces stress by ingesting daily as food-drinks etc. easily.
本発明者らは、上記課題を解決するために鋭意検討を重ねた結果、下記のストレス低減用食品組成物等により上記課題を解決できることを見出し、本発明を完成させた。 As a result of intensive studies in order to solve the above problems, the present inventors have found that the above problems can be solved by the following food composition for stress reduction and the like, and have completed the present invention.
すなわち、本発明は以下の通りである。
[1]バニリン及びボルネオールの少なくとも一方を有効成分として含有する、ストレス低減用食品組成物。
[2]バニリンの含有量が40〜400重量ppbである[1]に記載のストレス低減用食品組成物。
[3]ボルネオールの含有量が4〜40重量ppbである[1]または[2]に記載のストレス低減用食品組成物。
[4]飲料である[1]〜[3]のいずれか1に記載のストレス低減用食品組成物。
[5]バニリン及びボルネオールの少なくとも一方を有効成分として含有する、ストレス低減用剤。
That is, the present invention is as follows.
[1] A food composition for stress reduction containing at least one of vanillin and borneol as an active ingredient.
[2] The food composition for stress reduction according to [1], wherein the content of vanillin is 40 to 400 wt ppb.
[3] The stress-reducing food composition according to [1] or [2], wherein the borneol content is 4 to 40 wt ppb.
[4] The food composition for stress reduction according to any one of [1] to [3], which is a beverage.
[5] A stress reducing agent containing at least one of vanillin and borneol as an active ingredient.
本発明のストレス低減用食品組成物は、バニリン及びボルネオールの少なくとも一方を有効成分として含有することにより、リラックス促進作用、鎮静作用、抗不安作用及び自律神経調節作用を有し、これを摂取することによりストレスを低減することができる。 The stress-reducing food composition of the present invention contains at least one of vanillin and borneol as an active ingredient, thereby having a relaxation promoting action, a sedative action, an anxiolytic action, and an autonomic nerve regulating action, and taking this Therefore, stress can be reduced.
本発明のストレス低減用食品組成物(以下、本発明の食品組成物ともいう)は、バニリン及びボルネオールの少なくとも一方を有効成分として含有することを特徴とする。 The food composition for stress reduction of the present invention (hereinafter also referred to as the food composition of the present invention) is characterized by containing at least one of vanillin and borneol as an active ingredient.
本発明に用いるバニリンは、合成物であってもよいが、天然のバニリン含有植物から溶剤に溶解する成分を溶解させることにより抽出する抽出法で抽出された、天然バニラエキストラクト又は天然のバニラなどの抽出物から精製されたものであってもよい。また、天然バニラエキストラクトからストレス低減効果を阻害するバニリンの他の揮発性成分を除去したものであってもよい。 The vanillin used in the present invention may be a synthetic product, but natural vanilla extract or natural vanilla extracted by an extraction method in which a component that dissolves in a solvent is dissolved from a natural vanillin-containing plant. It may be purified from the extract. Moreover, what removed the other volatile component of the vanillin which inhibits a stress reduction effect from a natural vanilla extract may be used.
本明細書において、「天然バニラエキストラクト」は、キュアリング処理を施したバニラビーンズに、各種溶剤を抽出溶媒として作用させ、抽出した抽出液又はキュアリング処理を施したバニラビーンズから圧搾抽出した抽出液をいう。 In the present specification, “natural vanilla extract” is an extract obtained by pressing various kinds of solvents as an extraction solvent to a vanilla bean that has been subjected to a curing treatment, and by pressing and extracting from the extracted liquid or the vanilla beans that have undergone a curing treatment. Refers to liquid.
また、「天然バニラ」とは、ラン目ラン科バニラ属の果実であるバニラビーンズそのもの、あるいはバニラビーンズに物理的、化学的若しくは生物学的加工(キュアリングも含む)を単回行ったもの、各加工を組み合わせたもの、各加工を単独で若しくは組み合わせて複数回行ったもの、又はバニラビーンズそのもの及びバニラビーンズを前記加工したものに対し、抽出加工を行い、その結果出てくる残渣物、さらには得られた抽出物を再加工した結果出てくる残渣物をいう。 In addition, “natural vanilla” is a vanilla bean itself, which is a fruit of the orchidaceae vanilla genus, or a single physical, chemical or biological processing (including curing) on vanilla beans, What is combined with each processing, each processing is performed alone or in combination, multiple times, or vanilla beans themselves and those processed vanilla beans are subjected to extraction processing, the resulting residue, Refers to the residue produced as a result of reprocessing the obtained extract.
本発明の食品組成物における有効成分であるバニリンの含有量は、40重量ppb以上であることが好ましく、より好ましくは100重量ppb以上、さらに好ましくは200重量ppbである。また、400重量ppb以下であることが好ましく、より好ましくは350重量ppb以下、さらに好ましくは300重量ppb以下である。バニリンの含有量を前記範囲とすることにより、ストレス低減効果を十分に得ることができる。 The content of vanillin as an active ingredient in the food composition of the present invention is preferably 40 wt ppb or more, more preferably 100 wt ppb or more, and further preferably 200 wt ppb. Moreover, it is preferable that it is 400 weight ppb or less, More preferably, it is 350 weight ppb or less, More preferably, it is 300 weight ppb or less. By setting the vanillin content in the above range, a sufficient stress reduction effect can be obtained.
本発明に用いるボルネオールは合成物であってもよいが、竜脳香料(Dipterocarpaceae)に属する常緑高木である竜脳呑樹(Dryobalanops aromatic GAERTNER)の樹脂又は樹幹と枝を切って水蒸気で蒸留して得られる精製物であってもよい。 Borneol used in the present invention may be a synthetic material, but is obtained by distilling with water vapor from a resin or trunk of a tree or a trunk of an evergreen tree belonging to Dypterocarpacae. It may be a purified product.
本発明の食品組成物における有効成分であるボルネオールの含有量は、4重量ppb以上であることが好ましく、より好ましくは10重量ppb以上、さらに好ましくは20重量ppbである。また、40重量ppb以下であることが好ましく、より好ましくは35重量ppb以下、さらに好ましくは30重量ppb以下である。ボルネオールの含有量を前記範囲とすることにより、ストレス低減効果を十分に得ることができる。 The content of borneol as an active ingredient in the food composition of the present invention is preferably 4 wt ppb or more, more preferably 10 wt ppb or more, and further preferably 20 wt ppb. Moreover, it is preferable that it is 40 weight ppb or less, More preferably, it is 35 weight ppb or less, More preferably, it is 30 weight ppb or less. By making the content of borneol within the above range, a sufficient stress reduction effect can be obtained.
本発明の食品組成物は飲食品の形態として提供することができる。飲食品には、上記有効成分をそのまま、又はそれらを含む剤の形態で、配合することができる。飲食品の形態としては、例えば、顆粒状、粒状、ペースト状、ゲル状、固形状又は液体状に任意に成形することができる。 The food composition of the present invention can be provided as a form of food or drink. In the food and drink, the active ingredients can be blended as they are or in the form of agents containing them. As a form of food-drinks, it can shape | mold arbitrarily, for example in the shape of a granule, a granular form, a paste form, a gel form, solid form, or a liquid.
飲食品には、上記有効成分の他、栄養補助成分などの他の成分を含むことができる。かかる成分としては、例えば、ビタミン類、ミネラル類、各種植物体並びにその抽出物、精製物及び分画物、微生物並びにその増殖因子及び微生物生産物、食物繊維及びその酵素分解物、動物体並びにその抽出物、精製物、分解物及び生産物、各種オリゴ糖、脂質、各種タンパク質並びにタンパク分解物などが挙げられる。 In addition to the above active ingredients, the food and drink may contain other ingredients such as nutritional supplements. Examples of such components include vitamins, minerals, various plants and extracts thereof, purified products and fractions, microorganisms and growth factors and microorganism products thereof, dietary fibers and enzyme degradation products thereof, animal bodies and the like. Examples include extracts, purified products, degradation products and products, various oligosaccharides, lipids, various proteins, and protein degradation products.
また、飲食品に含有することが認められている公知の各種物質、例えば、結合剤、崩壊剤、滑沢剤、コーティング剤、増粘剤、分散剤、再吸収促進剤、矯味剤、緩衝剤、界面活性剤、溶解補助剤、保存剤、乳化剤、等張化剤、安定化剤又はpH調整剤などの賦形剤が挙げられる。 In addition, various known substances that are recognized to be contained in foods and drinks, such as binders, disintegrants, lubricants, coating agents, thickeners, dispersants, reabsorption accelerators, flavoring agents, buffering agents. And excipients such as surfactants, solubilizers, preservatives, emulsifiers, tonicity agents, stabilizers or pH adjusters.
飲食品の具体例としては、例えば、ジュース、清涼飲料水、乳飲料、茶飲料、機能性飲料、栄養補助飲料及びノンアルコールビール等の各種飲料;ビール及び発泡酒等のアルコール飲料;スープ、味噌汁及びお吸い物などの液状飲食品;飯類、餅類、麺類、パン類及びパスタ類等の炭水化物含有飲食品;クッキー及びケーキなどの洋菓子類、饅頭及び羊羹等の和菓子類、グミ類、タブレット類、キャンディー類、ガム類、チョコレート類並びにゼリー、ヨーグルト及びプリンなどの冷菓又は氷菓などの各種菓子類;卵を用いた加工品、及び魚介類又は畜肉の加工品;調味料;などが挙げられるが、これらに限定されるものではない。これらの中でも特に飲料が好ましい。 Specific examples of food and drink include, for example, juices, soft drinks, milk drinks, tea drinks, functional drinks, nutritional supplement drinks and non-alcoholic beer drinks; alcohol drinks such as beer and sparkling liquor; soup and miso soup Liquid foods and drinks such as soups; Carbohydrate-containing foods and drinks such as rice, rice cakes, noodles, breads and pasta; Western confectionery such as cookies and cakes; Japanese confectionery such as buns and sheepskin; Gummies and tablets Candy, gums, chocolates and various confectionery such as frozen confectionery or ice confectionery such as jelly, yogurt and pudding; processed products using eggs and processed products of seafood or livestock meat; seasonings; However, it is not limited to these. Among these, beverages are particularly preferable.
また、飲食品には、美容食品・健康食品、機能性表示食品、特定保健用食品、栄養補助食品、疾病リスク低減表示を付した食品、又は、病者用食品のような分類のものも包含される。機能性表示及び疾病リスク低減表示としては、例えば、ストレス関連症状を予防、改善、抑制及び/又は緩和するためのものである旨の表示が挙げられる。 In addition, foods and drinks include foods classified as beauty foods / health foods, functional labeling foods, foods for specified health use, dietary supplements, foods with a disease risk reduction label, or foods for the sick. Is done. Examples of the functional display and the disease risk reduction display include a display indicating that the stress-related symptoms are for prevention, improvement, suppression, and / or alleviation.
本発明の食品組成物は、精神的ストレス又は精神的プレッシャーが高まる期間の前又は最中に少なくとも1回、好ましくは一定時間をおいて数回摂取されることが好ましい。より好ましくは、ストレス要因が生じる前に少なくとも1回摂取される。また、精神的に過酷な状況の直前に摂取してもよい。 The food composition of the present invention is preferably taken at least once, preferably several times after a certain period, before or during a period of increased mental stress or mental pressure. More preferably, it is taken at least once before a stress factor occurs. It may also be taken immediately before a mentally harsh situation.
ストレス要因としては、例えば、試験、運転、プレゼンテーション、緊張の多いスポーツ・イベント、ビジネス・ミーティング、反復作業、知的労働、更年期における精神的不安定及び月経前の精神的不安定などが挙げられる。 Stress factors include, for example, exams, driving, presentations, stressful sporting events, business meetings, repetitive work, intellectual labor, mental instability in menopause, and premenstrual mental instability.
本発明の食品組成物を、ヒトを含む哺乳動物に経口的に摂取させる場合の摂取量は、当該哺乳動物の年齢、ストレス要因の高低、ストレスに対する感受性の程度などにより変動し、一概に規定することはできないが、体重1kg1日当たり、バニリン量として300〜3000ngが好ましく、また、ボルネオール量として30〜300ngが好ましい。 The amount of intake when the food composition of the present invention is taken orally by mammals including humans varies depending on the age of the mammal, the level of stress factors, the degree of sensitivity to stress, etc., and is generally defined. Although it is not possible, 300 to 3000 ng is preferable as the amount of vanillin per kg body weight per day, and 30 to 300 ng is preferable as the amount of borneol.
本発明の食品組成物を上記の様にして摂取することにより、リラックス促進作用、鎮静作用、抗不安作用及び自律神経調節作用が得られ、ストレスを低減することができる。また、本発明の食品組成物によりストレスを低減した結果、ストレスに起因する各種疾患の予防又は改善等も期待できる。 By ingesting the food composition of the present invention as described above, a relaxation promoting action, a sedative action, an anxiolytic action and an autonomic nerve regulating action can be obtained, and stress can be reduced. In addition, as a result of reducing stress by the food composition of the present invention, prevention or improvement of various diseases caused by stress can be expected.
以下、実施例を挙げて本発明を詳細に説明するが、本発明はこれらの実施例に何ら限定されるものではない。 EXAMPLES Hereinafter, although an Example is given and this invention is demonstrated in detail, this invention is not limited to these Examples at all.
実施例1:鎮静効果(活動量の評価)
バニリンおよびボルネオールがマウスの活動量に与える影響を赤外線による活動量により評価した。6週齢以上のICRマウス(雄)を体重に従って群分け(8匹/群)したものを試験動物として用いた。
Example 1: Sedative effect (evaluation of activity)
The effect of vanillin and borneol on the activity of mice was evaluated by the activity of infrared rays. A group of 6 or more ICR mice (male) grouped according to body weight (8 animals / group) was used as a test animal.
バニリン(ナカライテスク株式会社製、投与用量は0.0004mg/kg、0.004mg/kg、0.04mg/kg、0.4mg/kg又は4mg/kg b.w.)又はボルネオール(東京化成工業株式会社製、投与用量は0.000004mg/kg、0.00004mg/kg、0.0004mg/kg、0.004mg/kg又は0.04mg/kg b.w.)を0.5%カルボキシメチルセルロース水溶液に溶解したものを、前記試験動物に経口投与(投与容量10ml/kg b.w.)し、投与後から6.5時間までの間の活動量を測定した。
Vanillin (manufactured by Nacalai Tesque Co., Ltd., administered doses are 0.0004 mg / kg, 0.004 mg / kg, 0.04 mg / kg, 0.4 mg / kg or 4 mg / kg bw) or borneol (Tokyo Chemical Industry Co., Ltd.) Company-manufactured, 0.000004 mg / kg, 0.00004 mg / kg, 0.0004 mg / kg, 0.004 mg / kg or 0.04 mg / kg bw) dissolved in 0.5% aqueous carboxymethylcellulose solution The test product was orally administered to the test animals (
活動量は、自発運動量簡易測定センサー(株式会社ニューロサイエンス社製)を用いて、該装置が有するレンズによってマウスの体温(遠赤外線)を感知して1時間毎の活動回数をカウントした。結果を図1Aおよび図1Bに示す。 The amount of activity was counted by counting the number of activities per hour by sensing the body temperature (far infrared rays) of the mouse with the lens of the device using a sensor for simple measurement of spontaneous momentum (manufactured by Neuroscience Co., Ltd.). The results are shown in FIGS. 1A and 1B.
図1Aに示すように、マウスにバニリンを0.004〜0.04mg/kg b.w.の用量で単回投与した際に、活動量の低下が確認された。この投与用量を体表面積換算でヒト(60kg)に外挿すると、20〜200μgとなり、仮に500mL飲料に添加する場合最終濃度は40〜400重量ppbの濃度となる。 As shown in FIG. 1A, the mice received vanillin 0.004-0.04 mg / kg b. w. A decrease in activity was observed when a single dose was administered. Extrapolating this dose to humans (60 kg) in terms of body surface area results in 20-200 μg, and if added to a 500 mL beverage, the final concentration will be 40-400 wt ppb.
また、図1Bに示すように、マウスにボルネオールを0.0004〜0.004mg/kg b.w.の用量で単回投与した際に活動量の低下が確認された。この投与用量を体表面積換算でヒト(60kg)に外挿すると、2〜20μgとなり、仮に500mL飲料に添加する場合最終濃度は4〜40重量ppbの濃度となる。 In addition, as shown in FIG. 1B, Borneol was added to the mouse at 0.0004 to 0.004 mg / kg b. w. A decrease in activity was observed when a single dose was administered. Extrapolating this dose to humans (60 kg) in terms of body surface area yields 2-20 μg, and if added to a 500 mL beverage, the final concentration is 4-40 ppb.
実施例2:ストレス低減効果(心拍変動の測定)
バニリンおよびボルネオールが自律神経に与える影響を心拍変動によって評価した。6週齢以上のWistarラット(雄)を体重に従って群分け(7〜8匹/群)したものを試験動物として用いた。
Example 2: Stress reduction effect (measurement of heart rate variability)
The effects of vanillin and borneol on autonomic nerves were evaluated by heart rate variability. Wistar rats (male) 6 weeks of age or older were grouped (7-8 animals / group) according to body weight, and used as test animals.
経口投与する60分前から心拍の測定を開始し、バニリン(ナカライテスク株式会社製、投与用量は0.004mg/kg b.w.)又はボルネオール(東京化成工業株式会社製、投与用量は0.0004mg/kg b.w.)を0.5%カルボキシメチルセルロース水溶液に溶解したものを、前記試験動物に経口投与(投与容量10ml/kg b.w.)後120分間の心拍を測定した。心拍測定テレメトリー装置(DSI社製)を用いて測定した心拍変動から自律神経活動の指標であるLF/HFを算出し、自律神経活動を評価した。結果を図2Aおよび図2Bに示す。
Heart rate measurement was started 60 minutes before oral administration, and vanillin (Nacalai Tesque, Inc., dose: 0.004 mg / kg bw) or borneol (Tokyo Kasei Kogyo, dose: 0. 0004 mg / kg bw) dissolved in 0.5% carboxymethylcellulose aqueous solution was orally administered to the test animals (
図2Aおよび図2Bにそれぞれ示すように、バニリン(0.004mg/kg b.w.)、ボルネオール(0.0004mg/kg b.w.)、をラットに単回投与した際に、投与後のLF/HFが低値で推移することが確認された。この投与用量を体表面積換算でヒト(60kg)に外挿すると、バニリンでは40μg、ボルネオールでは4μgとなる。 As shown in FIG. 2A and FIG. 2B respectively, when a single dose of vanillin (0.004 mg / kg bw) or borneol (0.0004 mg / kg bw) was administered to a rat, It was confirmed that LF / HF remained low. Extrapolating this dose to humans (60 kg) in terms of body surface area yields 40 μg for vanillin and 4 μg for borneol.
実施例3:抗不安効果(明暗箱による評価)
バニリンおよびボルネオールの抗不安作用を、明暗箱により不安状態を評価する試験によって評価した。5週齢以上のDdyマウス(雄)を体重に従って群分け(7〜8匹/群)したものを試験動物として用いた。
Example 3: Anti-anxiety effect (evaluation by light and dark box)
The anti-anxiety effect of vanillin and borneol was evaluated by a test that evaluates the state of anxiety with a light and dark box. Ddy mice (male) 5 weeks of age or older grouped according to body weight (7-8 mice / group) were used as test animals.
試験を行う60分前にバニリン(ナカライテスク株式会社製、投与用量は0.0004mg/kg、0.004mg/kg又は0.4mg/kg b.w.)又はボルネオール(東京化成工業株式会社製、投与用量は0.0004mg/kg、0.004mg/kg又は0.4mg/kg b.w.)を0.5%カルボキシメチルセルロース水溶液に溶解したものを、前記試験動物に経口投与(投与容量10ml/kg b.w.)した。試験は、明箱と暗箱を連結させた装置にマウスを入れ、明箱への侵入回数、明箱における滞在時間を指標として、5分間実施した。結果を図3A〜図3Dに示す。
60 minutes before the test, vanillin (manufactured by Nacalai Tesque, Inc., administered dose is 0.0004 mg / kg, 0.004 mg / kg or 0.4 mg / kg bw) or borneol (manufactured by Tokyo Chemical Industry Co., Ltd., A dose of 0.0004 mg / kg, 0.004 mg / kg or 0.4 mg / kg bw) dissolved in 0.5% aqueous carboxymethylcellulose solution was orally administered to the test animals (
図3A〜図3Dにそれぞれ示すように、バニリン、ボルネオールともにマウス0.0004〜0.004mg/kgで単回投与した際に抗不安効果が確認された。この投与用量を体表面積換算でヒト(60kg)に外挿すると、2〜20μgとなる。 As shown in FIG. 3A to FIG. 3D, the anxiolytic effect was confirmed when vanillin and borneol were both administered at a dose of 0.0004 to 0.004 mg / kg in mice. Extrapolating this dose to humans (60 kg) in terms of body surface area yields 2-20 μg.
本発明の食品組成物は、リラックス促進作用、鎮静作用、抗不安作用及び自律神経調節作用を有し、これを摂取することによりストレスを低減する効果を有する。この特徴から、本発明の食品組成物は、ストレス関連症状を予防、改善、抑制及び/又は緩和するための新たな飲食品などとして利用されることが期待される。 The food composition of the present invention has a relaxation promoting action, a sedative action, an anxiolytic action and an autonomic nerve regulating action, and has the effect of reducing stress by ingesting this. From this feature, the food composition of the present invention is expected to be used as a new food or drink for preventing, improving, suppressing and / or alleviating stress-related symptoms.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016245132A JP6875117B2 (en) | 2016-12-19 | 2016-12-19 | Food composition for stress reduction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016245132A JP6875117B2 (en) | 2016-12-19 | 2016-12-19 | Food composition for stress reduction |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018100223A true JP2018100223A (en) | 2018-06-28 |
JP2018100223A5 JP2018100223A5 (en) | 2020-02-06 |
JP6875117B2 JP6875117B2 (en) | 2021-05-19 |
Family
ID=62714098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016245132A Active JP6875117B2 (en) | 2016-12-19 | 2016-12-19 | Food composition for stress reduction |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6875117B2 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999035917A1 (en) * | 1998-01-15 | 1999-07-22 | Edward Hirschberg | Methods of infusing phytochemicals, nutraceuticals, and other compositions into food products |
WO2006129876A1 (en) * | 2005-05-31 | 2006-12-07 | Kanebo Foods, Ltd. | Body odor improving agent for ingestion into body, beverage/food using the same, and method for improvement body odor |
US20120095087A1 (en) * | 2010-10-15 | 2012-04-19 | Keith Hyatt | Enhanced products by sustainable processes for medicinal use |
JP2012149042A (en) * | 2010-12-27 | 2012-08-09 | Sun Aroma:Kk | Mitigator for stress response acting on endocrine system, and mitigator or inhibitor mitigating or inhibiting symptom caused by stress response acting on endocrine system |
US20130089600A1 (en) * | 2011-07-11 | 2013-04-11 | Organic Medical Research | Cannabinoid formulations |
CN105748763A (en) * | 2016-02-22 | 2016-07-13 | 魏建萍 | Compound oral liquid for treating nervous headache and preparation method thereof |
-
2016
- 2016-12-19 JP JP2016245132A patent/JP6875117B2/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999035917A1 (en) * | 1998-01-15 | 1999-07-22 | Edward Hirschberg | Methods of infusing phytochemicals, nutraceuticals, and other compositions into food products |
WO2006129876A1 (en) * | 2005-05-31 | 2006-12-07 | Kanebo Foods, Ltd. | Body odor improving agent for ingestion into body, beverage/food using the same, and method for improvement body odor |
US20120095087A1 (en) * | 2010-10-15 | 2012-04-19 | Keith Hyatt | Enhanced products by sustainable processes for medicinal use |
JP2012149042A (en) * | 2010-12-27 | 2012-08-09 | Sun Aroma:Kk | Mitigator for stress response acting on endocrine system, and mitigator or inhibitor mitigating or inhibiting symptom caused by stress response acting on endocrine system |
US20130089600A1 (en) * | 2011-07-11 | 2013-04-11 | Organic Medical Research | Cannabinoid formulations |
CN105748763A (en) * | 2016-02-22 | 2016-07-13 | 魏建萍 | Compound oral liquid for treating nervous headache and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES, vol. 5(2), JPN6021001742, June 2016 (2016-06-01), pages 187 - 192, ISSN: 0004430436 * |
Also Published As
Publication number | Publication date |
---|---|
JP6875117B2 (en) | 2021-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11364268B2 (en) | Inactivated Bacillus coagulans and uses thereof for increasing physical performance | |
KR102178926B1 (en) | A composition for reinforcing immune function and anti-fatigue comprising fermented placenta and its use | |
KR101811122B1 (en) | A preparation method of jelly and beverage compositions containing Aronia extract reduced tannin and L-arginine | |
JP2008237117A (en) | Anti-fatigue food raw material and anti-fatigue food | |
JP2020128436A (en) | Bone fortifier dietary supplements | |
KR101318296B1 (en) | Composition for Prevention or Treatment of Osteoporosis Comprising Essential Oil of Zanthoxylum schinifolium | |
KR102039229B1 (en) | A Bacillus probiotics mixture for preventing or treating obesity, diabetes and fatty liver and uses thereof | |
JP2016222646A (en) | Composition comprising peptide for suppressing inflammation | |
JP5710091B2 (en) | NO production promoter | |
JP2006335725A (en) | Composition for improving bloodstream | |
JP6875117B2 (en) | Food composition for stress reduction | |
JP6498629B2 (en) | Food for suppressing blood neutral fat elevation | |
JP2007230881A (en) | Anti-fatigue composition | |
JP2018095580A (en) | Anxiolytic composition | |
JP2006143664A (en) | Improving agent of indefinite complaint accompanying with autonomic imbalance | |
KR101722297B1 (en) | ISOLATION OF SINGLE COMPOUND FROM Albatrellus fletti ITS APPLICATION IN TREATING AND PREVENTING OBESITY | |
KR101490794B1 (en) | Composition comprising alcohol extracts from oligoporus tephroleucus for treating or preventing hyperlipidemia | |
JP2006104094A (en) | alpha-GLUCOSIDASE INHIBITOR | |
JP2017002009A (en) | Adjuvant | |
Koguchi | Modification of dietary habits for prevention of gout in Japanese people: Gout and food intake | |
US20210161975A1 (en) | Inactivated bacillus coagulants and uses thereof for reducing stress | |
JP2019142976A (en) | Adjuvant | |
JP2019180412A (en) | Oral composition | |
JP6085872B2 (en) | Food for suppressing blood neutral fat elevation | |
JP6829487B2 (en) | Anti-fatigue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20190816 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20191216 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191216 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210126 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210226 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210406 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210422 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6875117 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |